~~<i id='100AF0D994'><strike id='100AF0D994'><tt id='100AF0D994'><pre id='100AF0D994'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：entertainment 2025-09-30 12:18:52 - browse：91936

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： More tobacco lobbyists active in statehouses

leisure time

focus

Wikipedia

hotspot

leisure time

knowledge

ColorizedmicroscopicimageofH5N1birdfluvirusparticles(inyellow).NIAIDAsagriculturalauthoritiesandepid

WSS

Diversity in clinical trials starts with building trust, experts say

Why does health care cost so much? A reading guide

Q&A: Jennifer Adair on making gene therapy available globally

UnitedHealth financials solid despite Change Healthcare cyberattack

FTC falls short on scrutinizing hospital mergers, study says

MassMutual is introducing free genetic testing for members

explore

knowledge

leisure time

Guidelines to prevent youth baseball injuries need more muscle

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Continuity nursing helped my family in our darkest PICU moments

Cholera vaccine supply gets boost as demand surges globally

As demand for Covid shots wanes, Moderna seeks its next success

Orangutan used medicinal plant to treat wound, first time ever seen

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Melinda French Gates resigns from Gates Foundation

The cancer drug shortage isn’t new — and neither are the solutions

Why does health care cost so much? A reading guide

focus

Melinda French Gates resigns from Gates Foundation

Why rehabilitation engineers need to center patients in their research

Orangutan used medicinal plant to treat wound, first time ever seen

Diversity in clinical trials starts with building trust, experts say

MassMutual is introducing free genetic testing for members

Diversity in clinical trials starts with building trust, experts say

Wikipedia

hotspot

leisure time

knowledge